Abstract This review focuses on how measured pre-and perinatal environmental and (epi)genetic risk factors are interrelated and potentially influence one, of many, common developmental pathway towards ADHD. Consistent with the Developmental Origins of Health and Disease hypothesis, lower birth weight is associated with increased ADHD risk. Prenatal ischemia-hypoxia (insufficient blood and oxygen supply in utero) is a primary pathway to lower birth weight and produces neurodevelopmental risk for ADHD. To promote tissue survival in the context of ischemia-hypoxia, ischemia-hypoxia response (IHR) pathway gene expression is altered in the developing brain and peripheral tissues. Although altered IHR gene expression is adaptive in the context of ischemia-hypoxia, lasting IHR epigenetic modifications may lead to increased ADHD risk. Taken together, IHR genetic vulnerability to ischemia-hypoxia and IHR epigenetic alterations following prenatal ischemia-hypoxia may result in neurodevelopmental vulnerability for ADHD. Limitations of the extant literature and future directions for genetically-informed research are discussed.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a chronic health condition characterized by persistent, pervasive, and developmentally inappropriate levels of inattention, hyperactivity-impulsivity, or both (American Psychiatric Association 2013). ADHD has an average prevalence rate of 5-5.5 % in youth (Polanczyk et al. 2007) , is more common in males (Polanczyk et al. 2007) , and generally persists into adulthood (Barbaresi et al. 2013) . It is also associated with high rates of psychiatric comorbidity (Angold et al. 1999) . The economic impact of ADHD in the United States is an estimated $143-$266 billion annually (Doshi et al. 2012) . In order to reduce the ADHD public health burden, there is a critical need to further understand the complex origins of ADHD and early etiological pathways to neurodevelopmental vulnerability.
Comprehensive theories of ADHD (Nigg 2005; Sonuga-Barke 2002) focus on multiple neurodevelopmental pathways to ADHD and provide a framework to conceptualize phenotypic heterogeneity within ADHD. Multiple genetic and prenatal environmental risk factors for ADHD have been identified; however, it is unclear how genetic and environmental risk factors coalesce to alter ADHD risk. Researchers have begun to examine how genetic pathways may impact molecular and cellular processes and ADHD risk (Poelmans et al. 2011; Yang et al. 2013 ); however, there remains a significant need to understand the role of prenatal environmental risk factors in the etiology of ADHD (Nigg 2012) .
Building on previous work linking prenatal hypoxia to ADHD (Lou 1996; Toft 1999) , this paper focuses on the interplay between genetic, epigenetic, and environmental risk to examine molecular pathways to ADHD, with a specific focus on the ischemia-hypoxia response pathway. To this end, we first briefly review empirical evidence and theory implicating prenatal ischemia-hypoxia (e.g., preeclampsia) and perinatal ischemia-hypoxia (e.g., birth asphyxia) in the development of ADHD and other neurodevelopmental disorders. Next, we focus on the potential role of genetic and epigenetic variation in genes shown to be involved in the ischemia-hypoxia response. Last, we review the similarities between neurodevelopmental sequelae of ischemia-hypoxia and neurodevelopmental correlates of ADHD. We conclude by discussing important methodological issues in this domain and suggestions for future research. The goal of the proposed model is to partially account for etiological heterogeneity in ADHD by articulating a putative developmental pathway from preand perinatal ischemia-hypoxia to ADHD risk.
Lower birth weight and ADHD risk: Preand perinatal ischemia-hypoxia as a shared determinant
Birth weight and ADHD risk
Lower birth weight is associated with a wide-range of chronic health and behavioral conditions (Boulet et al. 2011; Gluckman and Hanson 2004) and is one of the strongest, and most studied, risk factors for ADHD (Nigg et al. 2010; Thapar et al. 2013) . There is a dose-response relationship between lower birth weight and ADHD risk that is continuous in nature (Boulet et al. 2011; Phua et al. 2012; van Os et al. 2001 ). In addition, birth weight is associated with increased risk for ADHD over and above gestational age (Lahti et al. 2006) . When examined categorically, low birth weight (\2500 g) is associated with an approximately two to threefold increase in ADHD risk (Breslau et al. 1996; Linnet et al. 2006; Mick et al. 2002) after adjusting for covariates including child sex, SES, maternal stress, parental psychopathology, substance abuse, and maternal smoking (Breslau et al. 1996; Elgen et al. 2003; Horwood et al. 1998; Indredavik et al. 2004; Linnet et al. 2006; Zubrick et al. 2000) . Further, sibling comparison (Class et al. 2014) and discordant twin studies (Ficks et al. 2013; Groen-Blukhuis et al. 2011; Hultman et al. 2007 ) indicate that the relationship between birth weight and ADHD is not accounted for by genetic factors alone. Despite the well-established association between lower birth weight and ADHD, there is a paucity of research examining etiological pathways that both limit fetal growth and increase ADHD risk.
Prenatal ischemia-hypoxia, birth weight, and ADHD risk
The relationship between lower birth weight and ADHD is likely driven by precipitating environmental and genetic factors. Prenatal ischemia-hypoxia, or an insufficient supply of nutrients and oxygen to the developing fetus, is a primary pathway to lower birth weight (Henriksen and Clausen 2002; Kinzler and Vintzileos 2008) and prematurity (Salmaso et al. 2014) . Prenatal ischemia-hypoxia is implicated in a range of neurodevelopmental disorders, including ADHD (Getahun et al. 2013; Owens and Hinshaw 2013) , autism (Gardener et al. 2009; Kolevzon et al. 2007) , schizophrenia (Mittal et al. 2008; Schmidt-Kastner et al. 2012; Schmidt-Kastner et al. 2006) , and cerebral palsy (Derrick et al. 2007; Mwaniki et al. 2012) . In particular, obstetric complications associated with reduced nutrient and oxygen supply during the prenatal period (e.g., preeclampsia) or perinatal period (e.g., birth asphyxia) increase risk for ADHD (Getahun et al. 2013; Pineda et al. 2007 ) and ADHD-related comorbidity (Owens and Hinshaw 2013) . Furthermore, multiple prenatal environmental risk factors for ADHD (Froehlich et al. 2011) , such as maternal smoking (Bush et al. 2000; Knopik 2009 Knopik , 2010 Knopik et al. 2005 Knopik et al. , 2012 Knopik et al. , 2015 Knopik et al. , 2016 and maternal alcohol use (Bosco and Diaz 2012; Knopik et al. 2006 ) also lead to restricted fetal growth, partially through prenatal ischemiahypoxia (Table 1) . Genetically informed studies, however, demonstrate that the relationship between prenatal environmental risk factors, birth weight and ADHD is complex, and are at least partially accounted for by genetic factors (e.g., Thapar et al. 2009; Knopik et al. 2005 Knopik et al. , 2015 Knopik et al. , 2016 . Taken together, ischemia-hypoxia during pregnancy and delivery results from a range of obstetric conditions and fetal exposures, which limit fetal growth, and may account for a substantial portion of the ADHD disease burden (Fig. 1) .
Ischemia-hypoxia response (IHR)
In response to prenatal ischemia-hypoxia, the placentalfetal unit initiates a cascade of responses to preferentially allocate oxygen and nutrients to promote survival (Murray 2012) . Exposure to ischemia-hypoxia leads to changes in metabolic demand (Murray 2012; Wheaton and Chandel 2011) , angiogenesis (Shibuya 2008) , inflammatory/immune response (Ellison et al. 2005) , neuroprotective/neurotoxic systems (Myint et al. 2007 ), oxidative stress (Prabakaran et al. 2004) , and blood flow redistribution (Roza et al. 2008) . Importantly, all of these processes are also implicated in the etiology of ADHD (Lesch et al. 2013; Lou 1996; Lou et al. 2004; Oades 2011; Oades et al. 2010; Ribases et al. 2008; Roza et al. 2008; Sanchez-Mora et al. 2010; Todd and Botteron 2001) . Collectively, the ischemia-hypoxia response (IHR) may function to minimize damage to neural tissue from an ischemic-hypoxic pre-and perinatal environment.
Neurodevelopmental outcomes following ischemia-hypoxia exposure, however, are highly variable. Therefore, it is critical to identify genetic and epigenetic factors that might moderate or mediate the association between ischemia-hypoxia and ADHD. Most previous gene by environment interaction (GxE) studies in ADHD selected candidate genes that have shown an association with the disorder (see Nigg et al. 2010 ; for a review). This approach has a limited conceptual basis and may be related to the inconsistent findings in the ADHD GxE literature (Ficks and Waldman 2009 ). In contrast, candidate genes or pathways should be selected based on converging evidence from multiple sources (Dick et al. 2015) , including their functional significance in relation to the putative environmental pathogen (Moffitt et al. 2005 )-in this case, pre-and perinatal ischemia-hypoxia. We have shown that SNPs in angiogenic (NRP1 & NRP2), neurotrophic (NTRK1 & NTRK3), and inflammatory genes (CCBL1, CCBL2, IL16, S100B) moderate the association between birth weight centile and ADHD symptom severity (Smith et al. 2014) . These genetic systems have been implicated in the ischemia-hypoxia response and analyses in BrainCloud (Colantuoni et al. 2011 ) suggest many of these genes are expressed in the prefrontal cortex at relatively higher levels during prenatal development compared to later Fig. 1 Prenatal ischemia-hypoxia and the ischemia-hypoxia response are predicted to underlie the association between lower birth weight and ADHD. This model depicts how chronic prenatal ischemiahypoxia partially determines the association between lower birth weight and attention-deficit/hyperactivity disorder (ADHD) risk. Acute pre-or perinatal ischemia-hypoxia (e.g., umbilical cord prolapse) may still contribute to ADHD risk; however, birth weight may not be affected. IHR ischemia hypoxia-response development (See Supplementary Fig. 1 ). This provides preliminary evidence that developmental systems involved in the ischemia-hypoxia response are associated with ADHD risk and effects likely depend on prenatal environmental influences. Additionally, bioinformatic tools (Viswanathan et al. 2008) can assist in the identification of specific genes and genetic pathways that are implicated in the IHR. Of particular interest are genes that are functionally related to hypoxia inducible factor 1 or 2 (HIF-1; HIF-2), which regulate the cellular response to hypoxia and are expressed in the brain. HIFs promote adaptation to hypoxic conditions by regulating the transcription of IHR genes (Sharp and Bernaudin 2004) , which confer neurological and vascular adaptation (Schmidt-Kastner et al. 2006; Schmidt-Kastner et al. 2012; Sharp and Bernaudin 2004) . HIF-1 is necessary for normal embryonic (Yu et al. 1999) , neural, and vascular development (Tomita et al. 2003) . In addition, the vascular endothelial growth factor family is the main regulator of angiogenesis (i.e., the formation of new blood vessels; Shibuya 2008; Shibuya and Claesson-Welsh 2006) . The angiogenic system is implicated in ADHD etiology (Jesmin et al. 2004; Smith et al. 2014) and is upregulated in response to hypoxia, a process that is mediated by HIFs (Mac Gabhann and Popel 2008) and epigenetic mechanisms (Mimura et al. 2012; Skowronski et al. 2010) . Although the IHR aims to protect neural tissue from ischemia-hypoxia, IHR effects may persist and alter susceptibility for neurodevelopmental disorders later in life.
Developmental origins of ADHD: Epigenetic programming and neurodevelopmental risk
The Developmental Origins of Health and Disease hypothesis (DOHaD; Gluckman and Hanson 2004; Mill and Petronis 2008; Nigg 2012; Swanson and Wadhwa 2008 ) builds on the theory of ''fetal programming'' (Barker 2007) and provides an integrative framework to conceptualize the interplay between environmental, genetic and epigenetic factors in determining birth and health outcomes. Briefly, DOHaD posits that the prenatal environmental influences are associated with birth outcomes. This association is presumed to be mediated by epigenetic changes which allow the developing fetus to adapt the structure and function of developmental systems to promote survival. Additionally, prenatal environmental influences may disrupt or constrain developmental plasticity (see Gluckman and Hanson 2004) . To the extent that there is a mismatch between the prenatal and postnatal environments the individual may be ill-quipped to function adaptively in the postnatal environment. This mismatch confers vulnerability for later disease as the organism is functioning in an environment for which it was not epigenetically programmed to be adaptive in.
From a DOHaD perspective, the association between lower birth weight and ADHD may arise from a milieu of obstetric complications which lead to pre-and perinatal ischemia hypoxia. The placental-fetal unit will adapt to the ischemic-hypoxic environment by altering the structure and function of developmental systems, including the brain. Further, prenatal ischemia-hypoxia may lead to neural disruption (e.g., intraventricular hemorrhage; Whitaker et al. 2011) or place constraints on neurodevelopmental processes (e.g., cerebral blood flow; Fu and Olofsson 2011) . At the molecular level, the IHR response functions to promote survival in the context of cerebral ischemia-hypoxia. Consistent with DOHaD, however, the IHR response may leave ADHD-related brain regions illequipped to function in a nutrient and oxygen rich postnatal environment, increasing ADHD risk later in life. IHR genetic variability and ischemia-hypoxia induced epigenetic changes (described below) may confer increased risk or protection from ADHD, following pre-and perinatal environmental risk exposure (Mill and Petronis 2008) .
Ischemia-hypoxia induced epigenetic effects
Epigenetic mechanisms are a primary mechanism linking adverse intrauterine environments with later risk for disease (Wadhwa et al. 2009 ). Epigenetic changes in DNA methylation, histone modifications, and noncoding RNA have been shown, in part, to be induced by exposure to prenatal ischemia-hypoxia and alter gene expression (Watson et al. 2010 ). Ischemia-hypoxia induced epigenetic alterations are maintained in the absence of HIFs (Tsai and Wu 2013; Watson et al. 2010 ), suggesting they may continue to impact behavioral phenotypes later in life. DNA methylation, for example, is the addition of a methyl group to a cytosine in cytosine/guanine-rich DNA regions (Maccani and Marsit 2009) . When cytosines in the gene's promoter region are methylated, gene expression is generally reduced or silenced. Of note, lasting changes in global DNA methylation are observed in the rat brain following cerebral ischemia-hypoxia . Taken together, decreased nutrient and oxygen availability in utero may alter IHR gene expression (Schmidt-Kastner et al. 2012), through HIFs and epigenetic mechanisms, leading to altered susceptibility for ADHD and related outcomes ).
Pre-and perinatal ischemia-hypoxia and neurodevelopmental risk
Pre-and perinatal ischemia-hypoxia leads to lasting changes in neurodevelopmental functioning, especially in males (Mueller and Bale 2008) . This phenomenon may partially account for ADHD male preponderance (Jesmin et al. 2004; Laplante et al. 2012 ) and persistence overtime. Thus, it is critical to understand neurodevelopmental sequelae of prenatal ischemia-hypoxia and their relation to ADHD vulnerability. We briefly address four areas we believe to be of neurodevelopmental importance below: (i) neuroanatomical alterations, (ii) neurotransmission perturbation, (iii) neuroinflammation, and (iv) cerebral vascular response.
Neuroanatomical alterations
In animal models, chronic pre-and perinatal ischemiahypoxia is associated with reductions in brain weight, myelination, neurogenesis, synaptogenesis, and white matter damage (Bassan et al. 2010; Mallard et al. 1999) , as well as delays in interneuron, astroglia, and oligodendroglia maturation (Salmaso et al. 2014 ). Generally, these findings persist into adulthood (Rehn et al. 2004) . Numerous human studies highlight the association between fetal growth restriction (an indicator of pre-and perinatal ischemia-hypoxia) and neuroanatomical and neurocognitive outcomes. For instance, in a population-based study, lower birth weight predicted decreased anterior cingulate, caudate and total brain volume in childhood (Walhovd et al. 2012 ). Additionally, growth-restricted infants have reductions in overall white and gray matter compared to infants in the normal birth weight range (Brown et al. 2009; Larroque et al. 2003; Tolsa et al. 2004 ). These neuroanatomical findings relate to poor performance on measures of inattention and impulsivity (Peterson et al. 2003; Tolsa et al. 2004) and are consistent with neurocognitive findings in ADHD samples (Filipek et al. 1997; Kates et al. 2002; Mostofsky et al. 2002; Overmeyer et al. 2001) . Furthermore, within a low birth weight cohort, immature white matter lesions and ventricular enlargement, which are suggestive of ischemia-hypoxia exposure, predicted increased risk for ADHD (Whitaker et al. 1997 (Whitaker et al. , 2011 . Taken together, neurodevelopmental outcomes in pre-and perinatal ischemia-hypoxia animal models and human studies suggest neurodevelopmental delays or disruptions, which are functionally related to ADHD symptomatology.
Neurotransmisssion perturbation
Dopaminergic dysfunction remains of central interest for the pathophysiology and genetics of ADHD (Biederman and Faraone 2005; Castellanos and Tannock 2002; Swanson et al. 2007 ). The role of dopaminergic neurons, fibers, and synapses has been studied in animal models of pre-and perinatal ischemia-hypoxia (Boksa and El-Khodor 2003) . Loss of dopaminergic neurons has not been observed in perinatal models, but dysfunction such as imbalances in dopamine release and abnormal receptor expression have been reported (Boksa and El-Khodor 2003; Chen et al. 1997; Ungethum et al. 1996) . Bjelke et al. (1991) described increased numbers of tyrosine-hydroxylase positive, dopaminergic neurons in the substantia nigra in a perinatal anoxia model. The transcription factor HIF-1 has been related to the development of nigral dopamine neurons (Milosevic et al. 2007) and to dopamine toxicity (Lee et al. 2009 ). Interestingly, dopaminergic neurons of the mouse substantia nigra and ventral tegmental area express mainly ARNT as HIF-1 beta subunit and only low levels of ARNT2, contrasting with dual expression in cortical and hippocampal neuronal populations (Dela Cruz et al. 2014) . We have speculated that this expression pattern may limit the reaction of midbrain dopaminergic neurons to hypoxia (Dela Cruz et al. 2014) . In adult rats, lesions can be observed in the substantia nigra pars reticulata under severe ischemic conditions whereas the dopaminergic nigral neurons are resistant (Inamura et al. 1987) . The human striatum is vulnerable to perinatal ischemia-hypoxia (Lou et al. 2004) , and experimental studies show dysmaturation of striatal projection neurons following pre-natal hypoxia (McClendon et al. 2014) . The interaction between early striatal damage and dysfunction of the dopaminergic input remains to be understood. One intriguing hypothesis (Toft 1999 ) is that subtle damage to frontostriatal circuitry would lead to specific deficits in sustained attention and response inhibition underlying ADHD behavioral symptoms and related functional deficits (Gau et al. 2015) . Taken together, experimental evidence indicates that pre-and perinatal hypoxia can have lasting effects on the dopaminergic function, whereas neuronal death does not seem to play a role.
ADHD is also associated with altered glutamatergic transmission (Elia et al. 2012; Lesch et al. 2013 ). In contrast to findings related to dopaminergic functioning, prenatal ischemia-hypoxia leads to energy depletion in the fetal brain and neuronal apoptosis (cell death) from glutamate-induced excitotoxicity (Back and Rosenberg 2014) . Interestingly, neuronal energy deficiency has also been proposed as a biological underpinning of ADHD (Todd and Botteron 2001) .
Neuroinflammation
In response to prenatal ischemia-hypoxia and neuronal apoptosis, the immune system responds by increasing circulating pro-inflammatory cytokines, which further compromises fetal brain development (Jellema et al. 2013) . Pro-inflammatory cytokines may lead to increased bloodbrain barrier permeability (Kaur and Ling 2008) and excessive quinolinic acid, a glutamate receptor agonist, which at heightened levels is neurotoxic (Myint et al. 2007 ). Indeed, elevated levels of circulating cytokines in perinatal development are associated with multiple neurodevelopmental deficits (e.g., Krakowiak et al. 2015) , including ADHD diagnosis (Oades 2011) and ADHD neurocognitive endophenotypes (Oades et al. 2010 ).
Cerebral vascular response
Doppler velocimetry studies have shown that, in response to fetal hypoxia, the fetus increases distribution of blood flow to the brain (Fu and Olofsson 2006) . Though this ''brain-sparing flow'' may confer survival advantage in the moment, it is associated with decreased vascular plasticity in the future (Fu and Olofsson 2006) and increased risk for ADHD symptoms at 3 years of age (Roza et al. 2008) . Thus, fetal adaptations to prenatal ischemia-hypoxia and aberrant vascular adaptations may lead to increased vulnerability for later neurodevelopmental and behavioral problems.
Summary and research considerations
Converging lines of evidence indicate that ischemia-hypoxia is an early environmental pathogen for ADHD and related neurodevelopmental outcomes. Ischemia-hypoxia is a common element of multiple (often viewed as disparate) prenatal environmental risk factors, including low birth weight, prematurity, various obstetric complications, and maternal smoking during pregnancy (Table 1) . To promote the identification of etiological pathways to ADHD, it is important to consider the physiological sequelae of prenatal environmental risk factors. From this perspective, prenatal ischemia-hypoxia may initiate one common early etiological pathway to ADHD. Further, the IHR pathway highlights regions of the genome and epigenome that are particularly relevant to the development of ADHD, especially in the context of prenatal environmental risk. Further, preliminary evidence suggests that prenatal ischemiahypoxia may help to explain male preponderance of ADHD (Jesmin et al. 2004; Laplante et al. 2012) as well as phenotypic heterogeneity in ADHD symptomatology (Toft 1999; Gau et al. 2015) , persistence (e.g., Wu et al. 2013) and comorbidity (Owens and Hinshaw 2013) .To better elucidate mechanisms linking pre-and perinatal ischemiahypoxia and ADHD, consideration should be given to the following methodological issues.
First, there is little consensus on the most appropriate indicators of pre-and perinatal ischemia-hypoxia. Low birth weight is often utilized as a general proxy for an adverse intrauterine environment. Low birth weight, however, is multifactorial and may identify individuals who are either constitutionally small or premature, but not growth restricted (Maulik 2006) and not exposed to prenatal ischemia-hypoxia. Appropriately grown individuals that are born premature do not appear to be at increased risk for ADHD (Heinonen et al. 2010) . Therefore, in models of ADHD risk, it is more appropriate to utilize measures of fetal growth that adjust for gestational age as well as other covariates (e.g., sex, parity, and ancestry), such as customized birth centiles. Customized birth centiles may better capture vulnerability for ADHD due to limited nutrient and oxygen supply in utero compared to birth weight alone as they provide better estimates of growth potential. This measurement approach, however, is not proximally related to prenatal ischemia-hypoxia, prompting the need for more direct measures of prenatal ischemia-hypoxia in human studies, such as Doppler ultrasound assessment of fetal cerebral blood flow (e.g., Roza et al. 2008) .
Ischemia-hypoxia related obstetric complications during pregnancy and birth (see Table 1 ) may provide a more accurate measure of ischemia-hypoxia exposure. Creating a weighted summary score of chronic and acute pre-and perinatal risk factors allows for ischemia-hypoxia exposure severity to be measured on a continuum (Getahun et al. 2013; Lewis and Murray 1987) . In addition, directly measuring maternal-placental-fetal blood flow with Doppler ultrasound may provide a more direct measure of prenatal ischemia (Guvendag et al. 2013; Thuring et al. 2012) at the time of assessment. Further, placental pathology examination may provide researchers a physiological measure of limited placental-fetal blood and oxygen flow, which have previously been linked to autism (Walker et al. 2013) . Direct measures of prenatal ischemia-hypoxia in human studies are sorely needed to increase the public health impact of research in this domain.
Second, evidence from microarray gene expression studies in brain tissue of mice implicates a wide-range of genes in the ischemia-hypoxia response, which may play an important role in ADHD etiology, especially following an adverse intrauterine environment. Therefore, a multiomic approach is required to examine the interplay between prenatal environmental risk, genomic, epigenomic, and transcriptomic factors. This would involve integrating genomic, epigenomic and transcriptomic data within the IHR pathway. Analytical approaches for integrating multi-omic data are still in the early stages of development (Lasky-Su 2013). In addition, it is unclear how well epigenetic alternations and gene expression in the brain relate to levels in peripheral tissues (e.g., blood), which are accessible in human studies (Day et al. 2013; Tylee et al. 2013) . Studies examining tissue specificity and temporal stability of IHR epigenetic and expression changes in response to ischemia-hypoxia are needed. Leveraging developmental gene expression databases (e.g., Allen Brain Atlas; BrainCloud; BRAINSPAN) will help to target genes that are relevant to prenatal brain development.
Third, to complement epidemiological studies, there is critical need to leverage experimental and quasi-experimental designs in animals and humans, respectively. Experimental methods which leverage inbred strains of rodents provide the critical methodological control for genetic differences that otherwise obfuscate environmentally-induced epigenetic and expression differences in the IHR pathway. Genetically-informed human studies (e.g., co-twin, sibling comparisons, and children-of-twin) may help to further isolate causal prenatal environmental factors for ADHD and related neurodevelopmental disorders. Thus, utilizing epidemiological and experimental research methods in this domain will help to both identify specific pre-and perinatal environmental causes and molecular mechanisms linking prenatal ischemia-hypoxia exposure with ADHD risk.
In conclusion, prenatal ischemia-hypoxia and IHR genes and epigenetic mechanisms may initiate one, among many, possible developmental cascades that ultimately increases risk for ADHD and related neurodevelopmental outcomes. Multi-omic research linking prenatal ischemia-hypoxia with lasting neurodevelopmental vulnerability is needed to better elucidate the role of the IHR pathway in ADHD vulnerability. Such research may help to identify molecular mechanisms associated with neurodevelopmental risk/protection following exposure to an adverse pre-and perinatal environment. Ultimately, this research may inform preventative interventions for ADHD targeting individuals exposed to pre-and perinatal ischemia-hypoxia.
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